Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Up 34.1% in December

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 1,841 shares, an increase of 34.1% from the December 15th total of 1,373 shares. Based on an average trading volume of 34,654 shares, the short-interest ratio is currently 0.1 days. Based on an average trading volume of 34,654 shares, the short-interest ratio is currently 0.1 days.

Revolution Medicines Trading Down 9.6%

NASDAQ:RVMDW opened at $3.09 on Friday. Revolution Medicines has a one year low of $0.03 and a one year high of $3.59. The company has a fifty day moving average price of $1.10 and a 200 day moving average price of $0.56.

Revolution Medicines Company Profile

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.